*α*-Synuclein (*α*Syn) is a small, natively unfolded protein that is abundantly expressed in the central nervous system. It constitutes the major structural component of the intracellular protein inclusions termed Lewy bodies that define a pathological hallmark of Parkinson\'s disease (PD).^[@bib1]^ Mutations in or duplication and triplication of the gene coding for *α*Syn all result in familial PD.^[@bib2],\ [@bib3],\ [@bib4],\ [@bib5],\ [@bib6]^ An increasing body of evidence points towards a role for Ca^2+^ ions and Ca^2+^-dependent processes in the pathology of PD in general^[@bib7],\ [@bib8]^ and *α*Syn-mediated neuronal death during PD in particular.^[@bib9],\ [@bib10],\ [@bib11],\ [@bib12]^ The underlying mechanisms, however, remain enigmatic. A valuable tool to explore such pending questions are humanized yeast models based on heterologous expression of human *α*Syn and pathogenic mutants, as they have not only recapitulated several features of PD but have also allowed to identify novel and evolutionary-conserved mediators and processes involved in the cytocidal consequences of *α*Syn.^[@bib13],\ [@bib14],\ [@bib15],\ [@bib16],\ [@bib17]^ As the regulation of Ca^2+^ homeostasis is highly conserved between yeast and mammals -- with the advantage of reduced complexity and redundancy in yeast^[@bib18],\ [@bib19],\ [@bib20]^ -- we heterologously expressed human *α*Syn in yeast to elucidate its effect on Ca^2+^ homeostasis and cell death. We could identify the Golgi-resident Ca^2+^/Mn^2+^ ATPase PMR1 (plasma membrane-related Ca^2+^-ATPase 1) as mediator of *α*Syn -driven changes in Ca^2+^ homeostasis and cytotoxicity in yeast, nematodes and flies.

Results
=======

Heterologous expression of *α*Syn in yeast disrupts Ca^2+^ homeostasis
----------------------------------------------------------------------

We first quantified the basal cytosolic Ca^2+^ levels in yeast cells equipped with the Ca^2+^-dependent reporter protein aequorin at standard external \[Ca^2+^\] of ∼1 mM in the culture medium. In this setting, heterologous expression of *α*Syn provoked an elevation of the cytosolic Ca^2+^- concentration, \[Ca^2+^\]~cyt~, within the first 24 h of expression that subsided after 2 days of culturing ([Figure 1a](#fig1){ref-type="fig"}). Simultaneous determination of oxidative stress based on the superoxide-driven conversion of dihydroethidium to fluorescent ethidium (DHE→Eth) demonstrated that the rise in \[Ca^2+^\]~cyt~ triggered by *α*Syn ([Figure 1a](#fig1){ref-type="fig"}) coincided with an increase in oxidative stress. However, the \[Ca^2+^\]~cyt~ boost developed well before the massive production of reactive oxygen species (ROS), which started after 24 h of *α*Syn expression ([Figure 1b](#fig1){ref-type="fig"}), and subsequent cell death ([Figure 1c](#fig1){ref-type="fig"}). This points towards a sequential course of events, where *α*Syn-directed \[Ca^2+^\]~cyt~ increase occurs upstream of ROS generation and death. Immunoblot analysis revealed that *α*Syn (driven by a galactose-promoter) was well expressed throughout the experiment, accumulating around 8 h after promoter induction ([Figure 1e](#fig1){ref-type="fig"}). The transient, *α*Syn-induced increase in \[Ca^2+^\]~cyt~ was not related to a different localization of the protein itself, as -- in line with previous studies^[@bib15]^ -- green fluorescent protein (GFP)-tagged *α*Syn was prominently detectable at the plasma membrane within the first 2 days of expression ([Figure 1f](#fig1){ref-type="fig"}).

In addition to the disturbance in basal \[Ca^2+^\]~cyt~, *α*Syn altered the cellular response to high extracellular Ca^2+^ pulses. Upon challenge with 150 mM Ca^2+^, a rapid and transient increase in \[Ca^2+^\]~cyt~ was detectable that was largely amplified upon expression of *α*Syn ([Figure 1d](#fig1){ref-type="fig"}).

Addition of 2 mM ethylene glycol tetraacetic acid (a Ca^2+^ chelator) to the culture medium partly inhibited the increase in basal \[Ca^2+^\]~cyt~ and at the same time ameliorated *α*Syn-induced accumulation of ROS and cell death ([Figures 1g--i](#fig1){ref-type="fig"}). Similar results were obtained using another Ca^2+^ chelator, BAPTA-AM (1,2-bis-(o-Aminophenoxy)-ethane-N,N,N\',N\'-tetraacetic acid, tetraacetoxymethyl ester), which is cell-permeable and acts as intracellular Ca^2+^ sponge ([Supplementary Figures S1A and B](#sup1){ref-type="supplementary-material"}). Thus, inhibition of the rise in basal \[Ca^2+^\]~cyt~ attenuates subsequent ROS accumulation and death, indicating a causal link between disturbances in Ca^2+^ homeostasis and *α*Syn-inflicted cellular demise.

Oxidative stress and concomitant oxidation of DNA, proteins and lipids are essentially involved in neuronal cell death in various models of PD.^[@bib21],\ [@bib22],\ [@bib23]^ Therefore, we tested whether the thiolic antioxidant *N*-acetylcysteine (NAC), a precursor of glutathione that has been shown to be protective in several PD-associated neurodegenerative scenarios,^[@bib24],\ [@bib25],\ [@bib26],\ [@bib27]^ could block *α*Syn-induced generation of ROS and eventual cell death. Although supplementation with NAC did not prevent the first increase in ROS generation detectable within 24 h, it clearly inhibited massive ROS production and subsequent cell death occurring after 2 days of *α*Syn expression ([Figures 2a--c](#fig2){ref-type="fig"}). Basal \[Ca^2+^\]~cyt~ levels were largely unaffected by the addition of NAC ([Figure 2d](#fig2){ref-type="fig"}). By contrast, overexpression of cytosolic or mitochondrial superoxide dismutase (Sod1p or Sod2p, respectively) had no effect on *α*Syn-induced oxidative stress ([Supplementary Figures S2A and B](#sup1){ref-type="supplementary-material"}), arguing in favour of a rather broad pattern of cellular oxidative stress (that cannot by antagonized by overexpression of superoxid dismutases) as a cause of *α*Syn-induced cell death.

*α*Syn cytotoxicity in yeast is facilitated by PMR1
---------------------------------------------------

To identify molecular determinants for *α*Syn toxicity and dysregulation of Ca^2+^ homeostasis, we monitored *α*Syn-induced consequences in numerous deletion mutants known to influence Ca^2+^ transport or signalling. Yeast codes for various homologues of mammalian Ca^2+^ channels, transporters, sensors and buffers, including the plasma membrane-located voltage-dependent Ca^2+^ channel Cch1p/Mid1p, the secretory pathway and Golgi-resident Ca^2+^-ATPase Pmr1p, the sarcoendoplasmic reticulum Ca^2+^-ATPase Cod1p, the vacuolar H^+^/Ca^2+^ exchanger Vcx1p, the plasma membrane Ca^2+^-ATPase Pmc1p, the vacuolar cation channel Yvc1p -- a putative homologue of the mammalian transient receptor potential canonical channels -- or the general calcium sensor calmodulin as well as calcineurin and calmodulin-dependent kinases.^[@bib18],\ [@bib19],\ [@bib20]^ Using deletion mutants of these calcium-related regulators and automated quantification of ROS production, we evaluated the contribution of these proteins to *α*Syn cytotoxicity. This approach identified PMR1 as a mediator of *α*Syn-triggered ROS production ([Figures 3a and b](#fig3){ref-type="fig"}). In addition, the *α*Syn-driven development of apoptotic and necrotic markers -- assessed using AnnexinV/propidium iodide (PI) co-staining, which allows the discrimination between early apoptotic (AnnV^+^), late apoptotic/secondary necrotic (AnnV^+^/PI^+^) and necrotic (PI^+^) cells -- demonstrated that deletion of *PMR1* completely inhibited *α*Syn-driven increase in apoptotic and necrotic populations ([Figures 3c and d](#fig3){ref-type="fig"}). By contrast, the absence of *CCH1*, *MID1*, *PMC1*, *VCX1*, *YVC1*, or *COD1* did neither alter *α*Syn-instigated ROS-accumulation nor cell death markers as compared with wild type (WT; [Figures 3a--d](#fig3){ref-type="fig"}). Notably, deletion of these genes did not compromise *α*Syn expression ([Figure 3e](#fig3){ref-type="fig"}). Determination of survival using clonogenic survival plating assays showed that the absence of Pmr1p potently inhibited *α*Syn-induced cell death ([Figure 3f](#fig3){ref-type="fig"}). In addition, we generated a conditional *PMR1* mutant by replacement of the promoter region of *PMR1* with a tetO promoter that is active in the absence of doxycycline and prevents gene expression upon addition of 10 *μ*g/ml of the chemical.^[@bib28]^ Treatment of cells with doxycycline and thus depletion of Pmr1p largely reduced *α*Syn-induced ROS production, confirming that Pmr1p is essentially involved in *α*Syn cytotoxicity ([Figures 3g and h](#fig3){ref-type="fig"}).

To test whether *α*Syn has any effect on the localization and/or expression levels of Pmr1p, we performed fluorescence microscopy as well as immunoblot analyses of yeast cells endogenously expressing a Pmr1p-GFP fusion protein. No obvious effect on Pmr1p protein levels or Golgi localization was apparent ([Figures 4a and b](#fig4){ref-type="fig"}). Using reverse transcription quantitative PCR, we could detect a slight upregulation of PMR1 mRNA (normalized to actin mRNA) after 14 h of *α*Syn expression ([Figure 4c](#fig4){ref-type="fig"}).

We next analysed whether the rise in basal \[Ca^2+^\]~cyt~ triggered by *α*Syn is connected to the upregulation of a specific Ca^2+^ influx system that has been shown to be stimulated in scenarios such as the accumulation of misfolded proteins in the endoplasmic reticulum,^[@bib29]^ different defects in vesicular trafficking^[@bib30],\ [@bib31]^ and depletion of Ca^2+^ from the endoplasmic reticulum, for example, upon *PMR1* deficiency.^[@bib32],\ [@bib33]^ In all of these cases, a high rate of Ca^2+^ uptake via upregulation/activation of a high-affinity Ca^2+^ influx system that involves Cch1p and Mid1p is triggered.^[@bib34]^ Resultant elevated basal \[Ca^2+^\]~cyt~ levels lead to the activation of Ca^2+^ signalling pathways essential for initiation of compensatory mechanisms and subsequent cell survival.^[@bib34]^

Using quantitative PCR, we could indeed detect that after 14 h of expression, *α*Syn significantly amplified CCH1 mRNA levels and slightly upregulated MID1 mRNA ([Figure 4d](#fig4){ref-type="fig"}). As shown for PMR1 mRNA levels ([Figure 4c](#fig4){ref-type="fig"}), this effect faded after 24 h ([Figure 4d](#fig4){ref-type="fig"}). Given these results, we tested whether proteins involved in the calmodulin/calcineurin pathway and thus responsible for cellular Ca^2+^ sensing might alter *α*Syn-instigated cytotoxicity. Determination of ROS production demonstrated that *α*Syn toxicity was mostly unaffected by deletion of genes coding for the calcineurin-responsive zinc finger transcription factor Crz1p and the calmodulin-dependent kinases Cmk1p and Cmk2p, while the absence of Cnb1p, the regulatory subunit of calcineurin (and to some extent the absence of Cna2p, one of two isoforms of the catalytic subunit of calcineurin), did aggravate and expedite *α*Syn-induced oxidative stress ([Figure 4e](#fig4){ref-type="fig"}). Thus, an intact and functional Ca^2+^ signalling pathway that essentially involves calcineurin might contribute to a compensatory mechanism that partly counteracts and/or delays the toxic consequences of *α*Syn expression.

Pmr1p mediates *α*Syn-induced dysregulation of Ca^2+^ homeostasis
-----------------------------------------------------------------

Next, we analysed whether the absence of proteins mediating cellular Ca^2+^ transport modified the *α*Syn-induced raise in cytosolic Ca^2+^ levels. Consistent with a link between *α*Syn-mediated toxicity and dysregulation of Ca^2+^-homeostasis, expression of *α*Syn increased basal \[Ca^2+^\]~cyt~ in all deletion mutants except in Δ*pmr1* cells ([Figure 5a](#fig5){ref-type="fig"}). In line with previous studies,^[@bib35]^ deletion of *PMR1* already caused increased basal \[Ca^2+^\]~cyt~ as visible in the baseline recordings in [Figure 5b](#fig5){ref-type="fig"}. Furthermore, the absence of Pmr1p largely inhibited *α*Syn-induced amplification of rapid, transient cytosolic Ca^2+^ peaks upon addition of 150 mM Ca^2+^ ([Figure 5b](#fig5){ref-type="fig"}). Although this remained mostly unaffected upon deletion of *MID1*, *PMC1*, *VCX1* and *YVC1*, the absence of *CCH1* or *COD1* elevated the cellular response to external Ca^2+^ pulses *per se* and prevented further peak amplification by *α*Syn ([Supplementary Figures S3A--F](#sup1){ref-type="supplementary-material"}). Similar expression levels of aequorin were observed in all mutants ([Figure 5c](#fig5){ref-type="fig"}). Moreover, measurement of the transient elevation of \[Ca^2+^\]~cyt~ following the addition of glucose to glucose-starved cells demonstrated that again *α*Syn provoked an increase in \[Ca^2+^\]~cyt~ peak amplitude, which was inhibited in Δ*pmr1* cells ([Figure 5d](#fig5){ref-type="fig"}) but present in all other deletion mutants tested ([Figure 5e](#fig5){ref-type="fig"}). Thus, Pmr1p is crucially involved in the cellular consequences following *α*Syn expression, including (i) elevation of basal \[Ca^2+^\]~cyt~, (ii) deregulation of the rapid cellular response to sudden external glucose or high Ca^2+^ pulses, and (iii) accumulation of ROS and subsequent death.

Ca^2+^ rather than Mn^2+^ transport activity of Pmr1p contributes to *α*Syn toxicity
------------------------------------------------------------------------------------

The primarily Golgi-resident pump Pmr1p not only supplies Ca^2+^ to both the Golgi complex and the endoplasmic reticulum but also constitutes an important route to detoxify excess manganese, providing Mn^2+^ for protein glycosylation in the Golgi complex.^[@bib36]^ Thus, deletion of *PMR1* results in (i) depletion of endoplasmic reticulum Ca^2+^ stores,^[@bib33]^ which in turn causes elevated \[Ca^2+^\]~cyt~ via increased Ca^2+^ uptake, as well as in (ii) hypersensitivity to manganese.^[@bib36]^ Defects in cellular manganese homeostasis as well as exposure to manganese have been associated with PD and PD-like syndroms in humans^[@bib37],\ [@bib38]^ and several model systems.^[@bib39],\ [@bib40],\ [@bib41],\ [@bib42],\ [@bib43]^ Thus, we performed spotting assays on galactose plates containing high levels of manganese, demonstrating that exposure to manganese slightly aggravated *α*Syn-instigated cytotoxicity in concentrations that did not affect isogenic control cells (2 mM and 4 mM Mn^2+^ ions, respectively; [Figure 6a](#fig6){ref-type="fig"}). Upon *PMR1* deletion, Mn^2+^ was highly toxic ([Figures 6a and b](#fig6){ref-type="fig"}).

Furthermore, we generated strains that overexpress Pmr1p alone or in combination with *α*Syn and subjected these strains to spotting and clonogenic survival assays on galactose plates with and without manganese. Notably, high levels of Pmr1p were *per se* toxic to yeast cells, and combined overexpression of Pmr1p and *α*Syn killed \>95% of all cells ([Figures 6b and c](#fig6){ref-type="fig"}). Complementation analyses in *PMR1*-deficient cells demonstrated that expression of Pmr1p could (i) restore *α*Syn cytotoxicity and (ii) supress manganese toxicity ([Figures 6b and c](#fig6){ref-type="fig"}).

To further investigate the contribution of Ca^2+^ *versus* Mn^2+^ transport activity of Pmr1p to the toxic consequences of *α*Syn expression, we additionally transfected WT and *PMR1*-deficient cells with two point mutants of Pmr1p that were defective for transport of either Ca^2+^ ions (Pmr1p^D53A^) or Mn^2+^ ions (Pmr1p^Q783A^).^[@bib36],\ [@bib44]^ Compared with native Pmr1p, the overexpression of these point mutants in the background of WT cells still was less toxic than that of native Pmr1p, and both mutated variants were slightly less effective in enforcing *α*Syn cytotoxicity as determined in spotting assays and survival plating on galactose plates with and without addition of Mn^2+^ ([Figures 7a and b](#fig7){ref-type="fig"}). Conducting the same experiments in *PMR1*-deleted cells demonstrated that native Pmr1p and Pmr1p^Q783A^, which displays a selective loss of Mn^2+^ transport, both efficiently reinstated *α*Syn toxicity, whereas the Pmr1p^D53A^ variant deficient in Ca^2+^ transport partly lost this ability ([Figures 7a and b](#fig7){ref-type="fig"}). Native Pmr1p as well as Pmr1p^D53A^ expectedly suppressed manganese toxicity of *PMR1*-deficient cells, whereas Pmr1p^Q783A^ did not ([Figures 7a and b](#fig7){ref-type="fig"}). Expression of the Pmr1p variants and *α*Syn was confirmed in all strains ([Figure 7c](#fig7){ref-type="fig"}). These data indicate that the Ca^2+^ transport activity of Pmr1p -- rather than that of Mn^2+^ -- contributes to *α*Syn-induced cell killing.

*α*Syn neurotoxicity in nematodes and flies requires PMR1
---------------------------------------------------------

To test and challenge our finding *in vivo*, we analysed the effects of *PMR1* depletion on *α*Syn neurotoxicity in the nematode *Caenorhabditis elegans* and in the fruit fly *Drosophila melanogaster.* Nematodes expressing human *α*Syn directed by the dopamine transporter (*dat-1*) promoter were examined for survival of dopaminergic neurons. In WT nematodes, expression of *α*Syn resulted in the death of ∼40% of the dopaminergic neurons, while only ∼20% died in *PMR1*-deficient (*pmr-1(tm1840)*) animals ([Figure 8a](#fig8){ref-type="fig"}). Quantification of cytosolic Ca^2+^ levels in *α*Syn-expressing dopaminergic neurons using the Ca^2+^-sensitive fluorescent reporter protein GCaMP2.0^[@bib45]^ revealed that *α*Syn elevated the resting \[Ca^2+^\]~cyt~ in WT nematodes but not in *pmr-1(tm1840)* mutants ([Figure 8b](#fig8){ref-type="fig"}). In flies, the pan-neuronal *elav-GAL4*-driven expression of human *α*Syn significantly enhanced organismal death of male and female animals upon treatment with manganese. This effect was largely revised by RNA interference (RNAi)-mediated depletion of the Drosophila homologue of PMR1 (SPoCk) ([Figures 8c and d](#fig8){ref-type="fig"}). The absence of SPoCk did not affect the expression of *α*Syn ([Figure 8e](#fig8){ref-type="fig"}). As *α*Syn is known to provoke locomotive deficits and the selective loss of tyrosine hydroxylase-positive dopaminergic neurons in Drosophila PD models,^[@bib16],\ [@bib46]^ we tested for a possible involvement of SPoCk in these neurotoxic consequences. The *α*Syn-induced decline in negative geotaxis (which drives flies to walk upwards after being tapped to the bottom of a vial) was prevented by depletion of SPoCk ([Figure 8f](#fig8){ref-type="fig"}). Furthermore, expression of *α*Syn caused a significant loss of dopaminergic neurons in defined clusters of the brain, and this effect was absent when SpoCk was depleted ([Figures 8g and h](#fig8){ref-type="fig"}). Thus, the toxic consequences of *α*Syn expression in yeast, nematodes and flies essentially involve the Ca^2+^ ATPase PMR1.

Discussion
==========

Diverse Ca^2+^ signals govern a myriad of vital functions, including mechanisms of fundamental neuronal biology such as synaptic transmission, plasticity, regulated neurite outgrowth and synaptogenesis as well as pivotal generic processes like proliferation, transcription, differentiation and apoptosis. In particular, the mitochondrial cell death pathway is susceptible to elevated calcium concentrations.^[@bib47]^ Here, we establish that *α*Syn cytotoxicity is governed through sequentially occurring events, where the PMR1-dependent generation of a \[Ca^2+^\]~cyt~ increase precedes a burst of oxidative radicals that ultimately triggers cell death. In fact, the cytocidal effects of *α*Syn are reduced by treatment of cells with Ca^2+^ chelators or by *PMR1* deletion as well as via treatment with the generic antioxidant NAC. Thus, whether *α*Syn is able to trigger elevated basal cytosolic Ca^2+^ levels appears crucial for the subsequent cellular death. However, the transient \[Ca^2+^\]~cyt~ peaks following high external Ca^2+^ or glucose pulses in *α*Syn-expressing cells, while remaining a good predictor of toxicity, are not fully stringent, as under specific conditions (e.g., upon deletion of *COD1* or *CCH1*), high Ca^2+^ pulses were able to trigger massive transient \[Ca^2+^\]~cyt~ peaks without *α*Syn expression ([Figure 5](#fig5){ref-type="fig"} and [Supplementary Figure S3](#sup1){ref-type="supplementary-material"}). The prominent role of Ca^2+^ in *α*Syn-triggered cell death predicts that cellular Ca^2+^ sensing/signalling mechanisms may modulate the detrimental effects of *α*Syn expression. In fact, disruption of calcineurin signalling results in exacerbated toxicity, suggesting a compensatory mechanism based on the recognition of abnormal Ca^2+^ levels that partly counteracts the toxic consequences of *α*Syn. Cellular survival depends on tightly controlled Ca^2+^ fluxes between cellular organelles as well as across the plasma membrane. Impaired Ca^2+^ homeostasis and dysfunctional Ca^2+^ signalling are implicated in a broad variety of neurodegenerative diseases besides PD, including Alzheimer\'s disease, Huntington\'s disease, Glaucoma, Amyotrophic Lateral Sclerosis, Epilepsy and even the psychiatric disorder Schizophrenia.^[@bib48]^ Upon Ca^2+^ overload, mitochondria readily sequester and accumulate Ca^2+^, which leads to enhanced production of ROS, and subsequently to dissipation of mitochondrial transmembrane potential, opening of the mitochondrial permeability transition pore and cellular demise.^[@bib47]^ For *α*Syn-induced cell death in particular, where the lethal role of mitochondria has been clearly established,^[@bib14],\ [@bib49],\ [@bib50],\ [@bib51]^ the molecular axis of toxicity might therefore converge in this organelle.

Our findings establish Pmr1p as a conserved mediator of *α*Syn cytotoxicity in yeast, nematodes and flies and indicate a toxic role for Ca^2+^ in the pathology of PD. Enhancement of cytosolic calcium levels upon *α*Syn expression seems crucial for subsequent toxicity, a deadly road that requires PMR1.

Experimental Procedures
=======================

*Saccharomyces cerevisiae* strains, plasmids and media
------------------------------------------------------

Experiments were carried out in BY4741 (MATa *his3Δ1 leu2Δ0 met15Δ0 ura3Δ0*) and corresponding null mutants Δ*pmr1*, Δ*pmc1*, Δ*cch1*, Δ*mid1*, Δ*cod1*, Δ*vcx1*, Δ*yvc1*, Δ*cnb1*, Δ*cna1*, Δ*cna2*, Δ*crz1*, Δ*cmk1* and Δ*cmk2* as well as in BY4741 harbouring endogenously GFP-tagged PMR1 (Euroscarf, Frankfurt, Germany). Strains were grown on SC medium containing 0.17% yeast nitrogen base (Difco, BD Biosciences, Schwechat, Austria), 0.5% (NH~4~)~2~SO~4~ and 30 mg/l of all amino acids (except 80 mg/l histidine and 200 mg/l leucine), 30 mg/l adenine and 320 mg/l uracil with 2% glucose (SCD) or 2% galactose (SCG). Previously described *α*Syn-constructs in pESC-His (galactose promoter) or pUG23-His (methionine-repressible promoter)^[@bib14]^ or pGGE181 (constitutive promoter)^[@bib17]^ were deployed. To monitor cytosolic Ca^2+^ levels, strains were transformed with the pYX212 vector encoding cytosolic aequorin (pYX212-cytAEQ) (kind gift from E. Martegani, Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy). To construct a conditional *PMR1* mutant, the promoter region of *PMR1* has been replaced by a tetO promoter (which prevents gene expression upon addition of ≥10 *μ*g/ml doxycycline) following the protocol described by Yen *et al.*^[@bib28]^ Briefly, the *Kan*MX-*tetO*~*7*~ cassette has been amplified using pCM325 as template and the following primers: 5′-CAT TTT GTT ACA TCA AGA CAA GAT TCT CTA TTT AAA GAA GTA CGT ACG CTG CAG GTC GAC GG-3′ (forward) and 5′-AAT TAT CTT ATC TTT TAC TTA CAC TTA AGC TTA CGT CTG TGC TGG CAT AGG CCA CTA GTG GAT CTG-3′ (reverse). The amplified cassette has been integrated into the parental strain CML476 via homologous recombination.^[@bib28]^ To generate SOD1 and SOD2 constructs, inserts were amplified by PCR with primers 5′-ATC TGA ATT CAT GGT TCA AGC AGT CGC AG-3′ and 5′-ATC TAT CGA TGT TGG TTA GAC CAA TGA CAC C-3′ for SOD1 and 5′-ATC TGA ATT CAT GTT CGC GAA AAC AGC AGC-3′ and 5′-ATC TAT CGA TGA TCT TGC CAG CAT CGA ATC TTC-3′ for SOD2, cut with EcoRI and ClaI (Fermentas, Thermo Scientific, Vienna, Austria) and ligated into pUG35-Ura.^[@bib52]^ To generate *PMR1* and the two point mutants *PMR1*^*D53A*^ and *PMR1*^*Q783A*^ in pESC-Ura (Stratagene, Agilent Technologies, Vienna, Austria), previously described plasmids coding for Pmr1p or respective point mutants were used as templates^[@bib36],\ [@bib44]^ (kind gift of R. Rao, Johns Hopkins University, Baltimore, Maryland, USA). Inserts were amplified by PCR with the primers 5′-ATC TGC GGC CGC ATG AGT GAC AAT CCA TTT AAT GC-3′ and 5′-ATC TAC TAG TGT AAC ATT TGA GAA ATA CGT TGA GTC-3′, cut with NotI and SpeI (Fermentas) and ligated into pESC-Ura.

Analysis of *S. cerevisiae* survival, oxidative stress and apoptotic and necrotic changes
-----------------------------------------------------------------------------------------

To determine survival, oxidative stress, phosphatidylserine externalization and loss of membrane integrity upon expression of *α*Syn, cells from overnight cultures were inoculated in SCD to OD~600~ 0.1, grown to midlog phase and shifted to SCG for induction of *α*Syn expression. Clonogenic survival plating was performed as previously described.^[@bib53],\ [@bib54]^ Briefly, a CASY cell counter (Schärfe System, Reutlingen, Germany) was used to measure the cell counts and 500 cells were either plated on full-media YEPD (1% yeast extract, 2% Bacto peptone, 4% glucose; Difco) agar plates (to repress further galactose-driven expression of *α*Syn and/or Pmr1p and point mutants) or on selective galactose agar plates (to induce expression of *α*Syn and/or Pmr1p) supplemented or not with 1 mM, 2 mM or 4 mM MnCl~2~ as indicated. Colony-forming units were quantified after 2 days (YEPD plates) or 3 days (galactose plates) of growth using a Scanalyser Colony Counter (LemnaTec, Wuerselen, Germany). To measure the level of cellular oxidative stress, cultures were subjected to DHE staining at indicated time points, followed by quantification using a fluorescence reader or flow cytometry as previously described.^[@bib55]^ Externalization of phosphatidylserine and loss of membrane integrity was quantified after 48 h of *α*Syn expression using Annexin V/propidium iodide co-staining as previously described.^[@bib55]^ For quantifications using flow cytometry (FACSAria, BD Biosciences, Schwechat, Austria), 30 000 cells were evaluated and analysed with BD FACSDiva software. Same cells were visualized via epifluorescence microscopy on a Zeiss Axioskop microscope (Zeiss, Vienna, Austria). Notably, at least four different clones were tested after plasmid transformation to rule out clonogenic variations. For experiments with the Ca^2+^ chelators ethylene glycol tetraacetic acid and BAPTA-AM (Sigma, Vienna, Austria) and the antioxidant NAC (Sigma), cultures were either grown for 7 h after the shift on SCG for induction of *α*Syn expression and then supplemented with 2 mM ethylene glycol tetraacetic acid or 380 *μ*M BAPTA-AM or treated with 20 mM and 30 mM NAC directly after the shift. For spotting assays, cells were grown in SCG for 24 h, adjusted to 5·10^6^ cells/ml and spotted in fivefold serial dilutions onto glucose (expression repressed) and galactose (expression induced) agar plates supplemented or not with indicated concentrations of Mn^2+^.

*S. cerevisiae* cytosolic Ca^2+^ measurement
--------------------------------------------

\[Ca^2+^\]~cyt~ were measured using yeast strains carrying the vector pYX212 encoding the bioluminescent protein aequorin under the control of a TPI promoter. For analysis of resting, basal \[Ca^2+^\]~cyt~ and of the cellular response to high doses of external Ca^2+^, cells expressing *α*Syn under a galactose-inducible promoter (pESC-His) and equipped with pYX212-cytAEQ were inoculated in SCD to OD~600~ 0.1, grown to midlog phase and shifted to SCG for induction of *α*Syn expression. At indicated time points, an equivalent of 6·10^6^ cells was transferred into a 96 well plate and harvested by centrifugation. The pellets were resuspended in 200 *μ*l SCG containing 4 *μ*M coelenterazine and incubated for 1 h in the dark. To remove excess coelenterazine, the cells were washed once with fresh SCG and subsequently incubated for further 30 min. A LUMIstar Galaxy Luminometer (BMG Labtechnologies, Offenburg, Germany) was used to measure basal \[Ca^2+^\]~cyt~ as well as the response of \[Ca^2+^\]~cyt~ to external Ca^2+^ shocks. The basal luminescence was measured per well in 0.5-s intervals for 25 s, whereas for kinetic luminescence measurements the signal was recorded for 70 s. In order to investigate the kinetics of the cellular response to an external Ca^2+^ shock, a pump injected 40 *μ*l of a 0.8 M CaCl~2~ solution into each well. During all measurements, the plate was shaken and incubated at 28 °C. The luminescence signal was normalized to the OD~600~ of each well and reported in relative luminescence units.

For analysis of glucose-induced transients after glucose starvation, yeast cells constitutively expressing *α*Syn (using the pGGE181 plasmid) transformed with pYX212-cytAEQ were grown in selective medium with 2% glucose. Cells taken from stationary-phase pre-cultures were used to inoculate a new culture. When cultures reached an OD~600~ of±1.2, one OD~600~ unit of cells was plated on concanavaline A-coated coverslips and incubated at 30 °C for 1 h. Cells were subsequently washed with 0.1 M 2-(N-morpholino) ethanesulphonic acid (MES)/Tris, pH 6.5, which is a nutrient-free buffer, and again incubated for 1 h at 30 °C with 0.1 M MES/Tris pH 6.5 supplemented with 5 *μ*M wt coelenterazine (Promega, Mannheim, Germany). Excess of coelenterazine was removed by washing the cells three times with 0.1 M MES/Tris pH 6.5, and coverslips were mounted in a thermostated perfusion chamber (30 °C). Cells were initially perfused with 0.1 M MES/Tris pH 6.5, followed by 0.1 M MES/Tris pH 6.5 supplemented with 10 mM CaCl~2~. Cells were then stimulated by addition of 80 mM glucose to induce a [t]{.ul}ransient [e]{.ul}levation of [c]{.ul}ytosolic [C]{.ul}a^2+^ (TECC response) after glucose starvation.^[@bib56]^ At the end of the experiment, cells were lysed in a Ca^2+^-rich hypotonic medium (10 mM CaCl~2~ in H~2~O) containing 0.5% Triton X-100. The recorded aequorin luminescence data were calibrated offline into cytosolic Ca^2+^ values using the following algorithm \[Ca^2+^\]~cyt~=((*L*\'*L*~max~)^1/3^+\[118(*L*\'*L*~max~)^1/3^−1\])/(7 × 10^6^−\[7 × 10^6^(*L*\'*L*~max~)^1/3)^\]), where *L* is the luminescence intensity at any time point and *L*~max~ is the integrated luminescence.^[@bib57]^

*S. cerevisiae* immunoblot analysis
-----------------------------------

Immunoblot analysis of whole-cell extracts was performed as described.^[@bib53]^ Blots were probed with monoclonal antibodies against FLAG-epitope (Sigma), GFP (Sigma), glyceraldehyd-3-phosphate dehydrogenase (Sigma) and Aequorin (Abcam, Cambridge, UK) and the respective peroxidase-conjugated affinity-purified secondary antibodies (Sigma).

Reverse transcription quantitative PCR
--------------------------------------

To determine mRNA levels in yeast, total RNA was extracted from respective strains using Qiagen RNeasy kit (Qiagen, Hilden, Germany) with 5·10^8^ cells per extraction. Contaminating DNA was removed by DNase I digestion using Qiagen RNase-Free DNase Set and RNA was cleaned up according to the Qiagen RNA cleanup and concentration protocol. RNA concentrations were determined with a NanoDrop Spectrophotometer (NanoDrop Technologies, Thermo Scientific, Vienna, Austria), and 100 ng were used for detection of mRNA levels of PMR1, CCH1 and MID1 and of actin mRNA (as endogenous housekeeping gene) via reverse transcription and quantitative PCR amplification using SensiMixTM SYBR one-Step Kit (Bioline, Wiener Neudorf, Austria) and a Corbett Research RG6000 PCR machine (Qiagen). The following primers were used at a concentration of 300 nM: PMR1 primers 5′-TCCTTAGCGGTTGCTGCTAT-3′ (forward) and 5′-TCCTTAGCGGTTGCTGCTAT-3′ (reverse), CCH1 primers 5′-GCTACGGTAATGGGTTCAGC-3′ (forward) and 5′-CGCCTTTTCCTCAATGGTAA-3′ (reverse), MID1 primers 5′-CGAACGCTACCTCCACGTAT-3′ (forward) and 5′-GGCCTTACATCCCACTGAAA-3′ (reverse) and actin primers 5′-GCCTTCTACGTTTCCATCCA-3′ (forward) and 5′-GGCCAAATGATTCTCAAAA-3′ (reverse), all amplifying a length between 150 and 160 bp. Cycling conditions were 10 min at 42 °C and 10 min at 95 °C, followed by 40 cycles of 15 s at 95 °C, 15 s at 60 °C and 15 s at 72 °C. The obtained mRNA levels were normalized to the mRNA levels of the actin housekeeping gene within the same sample.

Statistical analysis
--------------------

A one-way ANOVA followed by a Bonferroni *post-hoc* test was used to calculate *P*-values. For survival of Drosophila, a two-way ANOVA with time and strain as independent factors followed by a Bonferroni *post-hoc* test was used.

*C. elegans* strains and genetics
---------------------------------

We followed standard procedures for *C. elegans* strain maintenance.^[@bib58]^ Nematode-rearing temperature was kept at 20 °C, unless noted otherwise. The following strains were used in this study: N2: WT Bristol isolate (wt), *pmr-1(tm1840)*, *Ex*\[p~*dat-1*~GCamP2.0\], *pmr-1(tm1840)X;Ex*\[p~*dat-1*~GCamP2.0\], BZ555: *egIs1*\[p~*dat-1*~GFP\], UA44: *baIn11*\[p~*dat-1*~*α*-Syn, p~*dat-1*~GFP\], *Ex*\[p~*dat-1*~*α*-Syn, p~*dat-1*~GCamP2.0\], *pmr-1(tm1840)X;Ex*\[p~*dat-1*~*α*-Syn, p~*dat-1*~GCamP2.0\] and *pmr-1(tm1840)X;Ex*\[p~*dat-1*~*α*-Syn, p~*dat-1*~GFP\]. The BZ555 and UA44 strains were generously provided by Guy Caldwell (Department of Biological Sciences, The University of Alabama).

*C. elegans* neurodegeneration analysis
---------------------------------------

Seven-day-old animals were used for *α*Syn-induced neurodegeneration quantification. The four CEP dopaminergic neurons in the worm of the head were scored as described previously.^[@bib59]^ Experiments were repeated four times, and statistical analyses were performed using the GraphPad Prism software package (GraphPad Software, San Diego, USA). Analysis of variance (ANOVA) was used for comparisons of multiple groups of values (in both approaches of neurodegeneration analysis), followed by Bonferroni multiple-group comparison tests.

*C. elegans* monitoring of cytosolic Ca^2+^ levels
--------------------------------------------------

For intracellular Ca^2+^ monitoring experiments, transgenic animals expressing the Ca^2+^ reporter GCaMP2.0^[@bib45]^ in dopaminergic neurons were examined under a Zeiss AxioImager Z2 epifluorescence microscope (Zeiss, Thessaloniki, Greece). The four CEP dopaminergic neurons in the worm of the head were imaged. Only neurons of very initial stages of degeneration (based on morphological features using DIC microscopy) were used for analysis, as the expression of GCaMP2.0 ceases during later stages of neurodegeneration. The emission intensity of GCaMP2.0 was calculated by using the ImageJ software (<http://rsb.info.nih.gov/ij/>).

*D. melanogaster* strains, genetics and survival
------------------------------------------------

The line UAS-*α*Syn was obtained from the Bloomington Stock Centre (Indiana University, USA). The UAS-CG32451RNAi (SPoCk, the Drosophila homologue of PMR1) line (transformant 110379) was obtained from the Vienna Drosophila RNAi Centre (Vienna, Austria). Lines overexpressing *α*Syn were crossed with the RNAi line to create the following stable stocks of flies: UAS-CG32451RNAi/ UAS-CG32451RNAi; UAS-*α*Syn/UAS-*α*Syn. A chromosome III-linked *elav-GAL4* enhancer trap line was used to drive expression. To determine survival upon challenge with manganese, 1--3-day-old flies (both sexes, kept separately) were incubated at 29 °C for 24 h and transferred into fresh vials with filter papers soaked with solution containing 10% sucrose and 20 mM MnCl~2~. Filters were kept wet at all times and numbers of dead flies were recorded at indicated time points. Each experiment was performed with 35--40 flies and repeated 12--20 times (as indicated in the respective figure legend).

*D. melanogaster* determination of locomotive ability
-----------------------------------------------------

To determine climbing ability upon supplementation of food with 20 mM Mn^2+^ ions for 24 h, eight female flies were placed into a vertical plastic tube with a diameter of 1.5 cm and gently tapped to the bottom. Flies reaching a specific mark (10 cm) within 10 sec were counted. Experiments were conducted in the dark (red light). Six trials of climbing were performed for each set of eight flies to determine the mean climbing activity per experiment, and at least six independent experiments were performed for each genotype.

*D. melanogaster* immunostaining and immunoblotting
---------------------------------------------------

Immunostaining was essentially performed as described before.^[@bib60]^ Brains were dissected in HL3 on ice, fixed in cold 4% PBS for 20 min and washed four times for 15 min in 0.3% PBT. After 1 h in PBT with 10% NGS at RT, brains were incubated for 2 days in PBT with 5% NGS containing primary antibodies against tyrosine hydroxylase (Millipore, Schwalbach, Germany) to detect dopaminergic neurons and against Bruchpilot (BRP^Nc82^) to visualize brain structure and then washed in PBT four times for 20 min. Subsequently, brains were incubated in PBT with 5% NGS, and the respective secondary antibodies labelled with FITC or Cy3 (Invitrogen, Darmstadt, Germany) for 1 day. Finally, brains were washed four times in PBT and transferred onto slides in Vectashield (Vector laboratories, Lörrach, Germany). Image acquisition was performed with a confocal microscope (TCS SP5, Leica Microsystems, Wetzlar, Germany) using the LCS AF software (Leica Microsystems). For immunoblot analysis, 20--30 fly heads were homogenized on ice in 50 *μ*l 2% SDS with protease inhibitor cocktail (Roche Diagnostics, Mannheim, Germany). Equal volume of 2 × Lämmli was added, samples were incubated at 95 °C for 5 min and then kept at RT for 5 min before centrifugation for 5 min at 13 000 × *g* and subsequent SDS-PAGE analysis. Blots were probed with primary antibodies against *α*-tubulin (Abcam) and *α*Syn (Sigma) and respective secondary antibodies.
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![Heterologous expression of *α*Syn elevates basal \[Ca^2+^\]~cyt~ and amplifies transient \[Ca^2+^\]~cyt~ responses in yeast. (**a**) Determination of basal cytosolic Ca^2+^ levels using aequorin-based luminescence measurement of WT yeast cells expressing human *α*Syn for indicated time or harbouring the empty vector (Ctrl.). Mean±S.E.M., *n*=8; \*\*\**P*\<0.001 and \*\**P*\<0.01. (**b**) Flow cytometric quantification of oxidative stress indicated by the superoxide-driven conversion of non-fluorescent dihydroethidium to fluorescent ethidium (DHE→Eth.) of WT yeast cells expressing human *α*Syn for indicated time or harbouring the empty vector (Ctrl.). Mean±S.E.M., *n*=8; \*\*\**P*\<0.001. (**c**) Survival determined by clonogenicity of WT yeast cells expressing human *α*Syn or harbouring the empty vector control for 24 h and 48 h. Cells were plated on YEPD agar plates. Mean±S.E.M., *n*=10; \*\*\**P*\<0.001. (**d**) Aequorin-equipped yeast cells harbouring the vector control or expressing *α*Syn for 16 h were challenged with 150 mM CaCl~2~ and transient \[Ca^2+^\]~cyt~ responses were observed for 70 s. Data was normalized to maximum peak amplitude of control cells. Mean±S.E.M., *n*=6. (**e**) Western blot analysis of *α*Syn expression in WT cells. Cells were harvested at indicated time points after induction of galactose-driven expression. Blots were probed with antibodies directed against FLAG-epitope to detect FLAG-tagged *α*Syn and against glyceraldehyd-3-phosphate dehydrogenase (GAPDH) as loading control. (**f**) Fluorescence microscopic analysis of WT cells expressing GFP-tagged *α*Syn (*α*Syn^GFP^) or harbouring the corresponding vector control (Ctrl.^GFP^) at indicated time points. (**g**) Determination of basal cytosolic Ca^2+^ levels using aequorin-based luminescence measurement of yeast cells expressing human *α*Syn or harbouring the empty vector (Ctrl.) after growth for 12 h, 20 h or 24 h on galactose media (promoter induction) supplemented or not with 2 mM ethylene glycol tetraacetic acid (EGTA). Data has been normalized to equally treated vector control cells. Mean±S.E.M., *n*=6; \*\**P*\<0.01 and \**P*\<0.05. (**h**) Flow cytometric quantification of oxidative stress by assessing the ROS-driven conversion of dihydroethidium to ethidium (DHE→Eth) upon expression of *α*Syn for indicated time and supplementation of media with 2 mM EGTA. Mean±S.E.M., *n*=4--8; \*\*\**P*\<0.001 and \*\**P*\<0.01. (**i**) Survival determined by clonogenicity of yeast cells expressing *α*Syn or harbouring the empty vector control for 48 h and supplementation of galactose medium with 2 mM EGTA. Cells were plated on YEPD agar plates. Mean±S.E.M., *n*=12; \*\*\**P*\<0.001](cdd2012142f1){#fig1}

![The antioxidant NAC inhibits *α*Syn cytotoxicity. (**a**) Survival determined by clonogenicity of yeast cells expressing *α*Syn or harbouring the empty vector. Galactose growth medium (for promoter induction) has been supplemented or not with 20 mM or 30 mM NAC as indicated and cells were plated on YEPD agar plates at day 1 and day 2 to determine survival. Mean±S.E.M., *n*=12--18. Significances have been calculated for day 2, with \*\*\**P*\<0.001 and \*\**P*\<0.01. (**b**) Flow cytometric quantification of oxidative stress by assessing the ROS-driven conversion of dihydroethidium to ethidium (DHE→Eth) of cells described in (**a**). Mean±S.E.M., *n*=8. Significances have been calculated for day 2, with \*\*\**P*\<0.001 and \**P*\<0.05. (**c**) Representative micrographs of dihydroethidium to ethidium (DHE→Eth) staining of cells expressing *α*Syn or harbouring the empty vector after supplementation of galactose growth medium with 20 mM NAC for 2 days as flow cytometrically quantified in (**b**). (**d**) Determination of basal cytosolic Ca^2+^ levels using aequorin-based luminescence measurement of yeast cells expressing *α*Syn or harbouring the empty vector after growth on galactose media supplemented or not with indicated concentrations of NAC for 20 h. Data has been normalized to equally treated vector control cells. Mean±S.E.M., *n*=8; \*\**P*\<0.01 and \**P*\<0.05](cdd2012142f2){#fig2}

![The Ca^2+^/Mn^2+^ ATPase Pmr1p mediates *α*Syn cytotoxicity. (**a** and **b**) Quantification via fluorescence reader (**a**) and representative micrographs (**b**) of ROS production by assessing the ROS-driven conversion of dihydroethidium to ethidium (DHE→Eth) upon expression of *α*Syn for 24 h in WT yeast cells and indicated deletion mutants. Mean±S.E.M., *n*=8; \*\*\**P*\<0.001 and \*\**P*\<0.01. (**c** and **d**) Flow cytometric quantification (**c**) and representative micrographs (**d**) of externalization of phosphatidylserine (AnnV^+^) and loss of membrane integrity (PI^+^) by Annexin V/PI co-staining of WT cells and indicated deletion mutants expressing *α*Syn for 48 h. Mean±S.E.M., *n*=6; \*\*\**P*\<0.001. (**e**) Western blot analysis of *α*Syn expression in WT cells and indicated deletion mutants. Blots were probed with antibodies against FLAG-epitope to detect FLAG-tagged *α*Syn and against glyceraldehyd-3-phosphate dehydrogenase (GAPDH) as loading control. (**f**) Survival determined by clonogenicity of WT and Δ*pmr1* yeast cells expressing *α*Syn or harbouring the vector control after 24 h and 48 h of expression on galactose media and plating on YEPD agar plates. Mean±S.E.M., *n*=10; \*\*\**P*\<0.001. (**g**) Quantification of ROS accumulation (DHE→Eth) in yeast cells in which the promoter region of *PMR1* has been replaced by a doxycycline-repressible promoter (*TetO*-*PMR1*). Doxycycline (Doxy) was added in indicated concentrations and *α*Syn was expressed for 24 h or 48 h. Mean±S.E.M., *n*=8; \*\*\**P*\<0.001. (**h**) Q-PCR-based quantification of PMR1 mRNA levels in yeast cells described in (**g**) after treatment with 10 *μ*g/ml Doxycycline (Doxy) and *α*Syn expression for 12 h. Data have been normalized to mRNA levels of actin. Means±S.E.M., *n*=3. Asterisks indicate significance between untreated and Doxy-treated cells, \*\*\**P*\<0.001](cdd2012142f3){#fig3}

![Expression of *α*Syn causes a slight upregulation of PMR1 and CCH1 mRNA levels. (**a**) Representative micrographs of yeast cells expressing endogenously GFP-tagged Pmr1p in combination with *α*Syn or corresponding vector control at indicated time points after induction of *α*Syn expression. (**b**) Western blot analysis of cells described in (**a**) at indicated time points after induction of *α*Syn expression. Blots were probed with antibodies against GFP to detect Pmr1p-GFP fusion protein, against FLAG-epitope to detect FLAG-tagged *α*Syn and against glyceraldehyd-3-phosphate dehydrogenase (GAPDH) as loading control. (**c** and **d**) Q-PCR-based quantification of PMR1 mRNA levels (**c**) and of CCH1 and MID1 mRNA levels (**d**) in WT cells expressing *α*Syn or harbouring the empty vector control for 14 h or 24 h, respectively, normalized to actin mRNA levels. Means±S.E.M., *n*=6--9; \**P*\<0.05. (**e**) Quantification of ROS accumulation (DHE→Eth) in WT yeast cells and indicated deletion mutants expressing *α*Syn for 16 h or 24 h using a fluorescence reader. Mean±S.E.M., *n*=6; \*\*\**P*\<0.001 and \**P*\<0.05](cdd2012142f4){#fig4}

![Pmr1p is involved in *α*Syn-induced dysregulation of Ca^2+^ homeostasis. (**a**) Aequorin-luminescence-based determination of basal cytosolic Ca^2+^ levels in WT cells and indicated deletion mutants expressing *α*Syn for 20 h. Data was normalized to corresponding isogenic vector control. Mean±S.E.M., *n*=12; \*\*\**P*\<0.001; NS, not significant. (**b**) Aequorin-equipped WT and Δ*pmr1* yeast cells expressing *α*Syn or harbouring the vector control were challenged with 150 mM CaCl~2~ and transient \[Ca^2+^\]~cyt~ responses were observed for 50 s. Mean±S.E.M., *n*=6. (**c**) Western blot analysis of aequorin expression and *α*Syn expression in WT cells and indicated deletion mutants. Blots were probed with antibodies directed against aequorin, against FLAG-epitope to detect FLAG-tagged *α*Syn and against glyceraldehyd-3-phosphate dehydrogenase (GAPDH) as loading control. (**d**) Aequorin-equipped WT and Δ*pmr1* cells constitutively expressing *α*Syn (using the expression vector pGGE181) or harbouring the empty pGGE181 vector (Ctrl.) were starved for glucose, supplemented with low doses of Ca^2+^ (10 mM) and subsequently challenged with 80 mM glucose. Transient \[Ca^2+^\]~cyt~ responses were monitored. Data represent average recordings, *n*≥9. (**e**) Maximum \[Ca^2+^\]~cyt~ peak amplitude after addition of 80 mM glucose as depicted in (**d**) in aequorin-equipped WT cells and indicated deletion mutants upon expression of *α*Syn. Mean±S.E.M., *n*≥9; \*\*\**P*\<0.001; NS, not significant](cdd2012142f5){#fig5}

![Expression of Pmr1p restores *α*Syn cytotoxicity and supresses manganese toxicity of *PMR1*-deficient cells. (**a**) Spotting assays of WT and Δ*pmr1* yeast cells expressing *α*Syn or harbouring the vector control. Cells were grown for 24 h in galactose media and spotted in fivefold serial dilutions onto glucose (*α*Syn expression repressed) and galactose (*α*Syn expression induced) agar plates supplemented or not with 2 mM or 4 mM Mn^2+^, respectively. (**b**) Spotting assays of WT and Δ*pmr1* yeast cells expressing either *α*Syn or Pmr1p alone or in combination or harbouring the corresponding vector controls. Cells were grown for 24 h in galactose media and spotted in fivefold serial dilutions onto glucose (Pmr1p and *α*Syn expression repressed) and galactose (Pmr1p and *α*Syn expression induced) agar plates supplemented or not with 4 mM Mn^2+^. (**c**) Quantification of clonogenic survival of cells described in (**b**) after plating on galactose agar plates supplemented or not with 4 mM Mn^2+^. Both Pmr1p as well as *α*Syn expression are driven by a galactose promoter. Mean±S.E.M., *n*=8--12; \*\*\**P*\<0.001 and \*\**P*\<0.01; NS, not significant. Unless otherwise specified, asterisks indicate significances to similarly treated, isogenic control cells harbouring both empty vectors](cdd2012142f6){#fig6}

![Ca^2+^ rather than Mn^2+^ transport activity of Pmr1p contributes to *α*Syn toxicity. (**a**) Spotting assays of WT and Δ*pmr1* yeast cells expressing either Pmr1p or the point mutants Pmr1p^D53A^ and Pmr1p^Q783A^ alone or in combination with *α*Syn. Cells were grown for 24 h in galactose media and spotted in fivefold serial dilutions onto glucose (Pmr1p and *α*Syn expression repressed) and galactose (Pmr1p and *α*Syn expression induced) plates supplemented or not with 1 mM and 4 mM Mn^2+^. (**b**) Cells described in (**a**) were subjected to clonogenic survival plating on galactose plates supplemented or not with 1 mM Mn^2+^. Survival has been normalized to WT cells harbouring both empty vectors plated on galactose plates without manganese. Mean±S.E.M., *n*=12--16. (**c**) Western blot analysis of Pmr1p, Pmr1p^D53A^ and Pmr1p^Q783A^ overexpression as well as of *α*Syn expression in WT and Δ*pmr1* yeast cells. Blots were probed with antibodies directed against FLAG-epitope to detect FLAG-tagged Pmr1p variants and *α*Syn and against glyceraldehyd-3-phosphate dehydrogenase (GAPDH) as loading control](cdd2012142f7){#fig7}

![PMR1 is critical for *α*Syn neurotoxicity in nematodes and flies. (**a**) Survival of *C. elegans* dopaminergic neurons in WT or PMR-1-deficient (*pmr-1(tm1840)*) animals expressing GFP and *α*-Syn. Mean±S.E.M., *n*\>250 individual animals; \*\*\**P*\<0.001. (**b**) Fluorescence-based quantification of cytoplasmic Ca^2+^ levels in WT or PMR-1-deficient (*pmr-1(tm1840)*) nematodes expressing the Ca^2+^ indicator GCaMP2.0 and *α*-Syn. Mean±S.E.M., *n*\>150 dopaminergic neurons. \*\*\**P*\<0.001. (**c** and **d**) Survival of male (**c**) and female (**d**) WT flies and of flies either expressing human *α*Syn or an RNAi depleting SPoCk (the Drosophila homologue of PMR1) or both (driven by *elav-GAL4*) upon supplementation of food (10% sucrose) with 20 mM Mn^2+^. Means±S.E.M., *n*=12--20 with 35--40 flies per experiment; \*\*\**P*\<0.001. (**e**) Immunoblot analysis of brain lysats obtained from flies expressing human *α*Syn driven by *elav-GAL4* with or without co-expression of an RNAi-depleting SPoCk using antibodies directed against human *α*Syn or Drosophila *α*-tubulin as loading control. (**f**) Climbing activity of female flies described in (**d**) after 24 h of Mn^2+^ treatment. Means±S.E.M., *n*=6--10 with 8 flies per experiment; \*\*\**P*\<0.001 and \**P*\<0.05. (**g** and **h**) Total count of tyrosine hydroxylase (TH)-immunoreactive dopaminergic neurons (**g**) in the DM, PM and DL1 brain clusters of female flies expressing *α*Syn alone or in combination with an RNAi-depleting SPoCk after treatment with Mn^2+^ for 96 h. Representative confocal microscopy images of dissected brains immunostained for TH and for Bruchpilot (BRP^Nc82^) to visualize brain structure are shown in (**h**). Neuronal counts were quantified by inspection of the individual planes of the z-stack. Means±S.E.M., *n*=5--10; \*\**P*\<0.01 and \**P*\<0.05](cdd2012142f8){#fig8}
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